Perspective Therapeutics, Inc. Annual Selling and Marketing Expense in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Perspective Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2011 to 2022.
  • Perspective Therapeutics, Inc. Selling and Marketing Expense for the quarter ending September 30, 2023 was $855K, a 6.88% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Selling and Marketing Expense for 2022 was $2.8M, a 14.9% increase from 2021.
  • Perspective Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $2.44M, a 18% decline from 2020.
  • Perspective Therapeutics, Inc. annual Selling and Marketing Expense for 2020 was $2.98M, a 11.1% increase from 2019.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.8M +$364K +14.9% Jul 1, 2021 Jun 30, 2022 10-KT 2023-05-01
2021 $2.44M -$536K -18% Jul 1, 2020 Jun 30, 2021 10-KT 2023-05-01
2020 $2.98M +$297K +11.1% Jul 1, 2019 Jun 30, 2020 10-KT 2023-05-01
2019 $2.68M +$19K +0.71% Jul 1, 2018 Jun 30, 2019 10-K 2021-09-27
2018 $2.66M +$350K +15.2% Jul 1, 2017 Jun 30, 2018 10-K 2020-09-25
2017 $2.31M +$957K +70.7% Jul 1, 2016 Jun 30, 2017 10-K 2019-09-27
2016 $1.35M -$135K -9.07% Jul 1, 2015 Jun 30, 2016 10-K 2018-09-26
2015 $1.49M +$253K +20.5% Jul 1, 2014 Jun 30, 2015 10-K 2017-09-28
2014 $1.23M -$61.4K -4.74% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-09
2013 $1.3M +$80.6K +6.63% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-14
2012 $1.22M -$16.6K -1.35% Jul 1, 2011 Jun 30, 2012 10-K 2013-09-30
2011 $1.23M Jul 1, 2010 Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.